Submission Details
| 510(k) Number | K200279 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2020 |
| Decision Date | May 01, 2020 |
| Days to Decision | 87 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K200279 is an FDA 510(k) clearance for the ImmunoCAP Allergen o215, Component nGal-alpha-1,3-Gal(alpha-Gal) Thyroglobulin, bovine, a System, Test, Radioallergosorbent (rast) Immunological (Class II — Special Controls, product code DHB), submitted by Phadia AB (Uppsala, SE). The FDA issued a Cleared decision on May 1, 2020, 87 days after receiving the submission on February 4, 2020. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5750.
| 510(k) Number | K200279 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2020 |
| Decision Date | May 01, 2020 |
| Days to Decision | 87 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DHB — System, Test, Radioallergosorbent (rast) Immunological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5750 |